AeroLeads people directory · profile
Marco A. Chacón Email & Phone Number
Founder and President
at
Irazu Oncology
1 work email found
@paragonbioservices.com
2 phones found area 410
LinkedIn matched
✓ Verified July 2026
4 data sources
Profile completeness 100%
Current company
Role
Founder and President
Location
Baltimore, Maryland, United States
Who is Marco A. Chacón? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Marco A. Chacón is listed as Founder and President at Irazu Oncology, based in Baltimore, Maryland, United States. AeroLeads shows a work email signal at paragonbioservices.com, phone signal with area code 410, and a matched LinkedIn profile for Marco A. Chacón.
Marco A. Chacón previously worked as Chairman Of The Board at Center For Breakthrough Medicines and Founder & President at Irazú Bio. Marco A. Chacón holds Phd, Nutritional Sciences from University Of Maryland.
Company email context
Email format at Irazu Oncology
This section adds company-level context without repeating Marco A. Chacón's masked contact details.
*@paragonbioservices.com
68% confidence
AeroLeads found 1 current-domain work email signal for Marco A. Chacón. Compare company email patterns before reaching out.
Profile bio
About Marco A. Chacón
Marco A. Chacon, PhD., is the Founder & President of IRAZÚ BIO, a company dedicated to early stage technology development, while bridging the uncertainty divide between academic research and drug development. Leveraging innovative biochemical mechanisms described in hypoxia tolerant and neuroprotective phenotypes, including caloric restriction models, newborn mammals and hibernators, IRAZÚ is developing indications to promote survival, prevent disease and improve quality of life in old age. The company is also developing technology in the fields of immuno-oncology and gene therapy.Formerly, Chacon served as Assistant Vice President of Industry Alliances at the University of Maryland, Baltimore.Chacon is also the Founder and former Chairman of Paragon Bioservices, Inc., a contract development and GMP manufacturing organization (CDMO) that specialized in process development and GMP manufacturing of viral vectors for gene therapy. In May of 2019, Paragon was acquired by Catalent Pharma Solutions—a global CMO—for $1.2 Billion. The combined organization occupies ~ 2K square feet of space at three sites in Maryland, including The University of MD BioPark, Anne Arundel County and Gaithersburg. It is estimated that the company will have ~1K employees by the first quarter of 2020.Dr. Chacon’s academic interests include energy metabolism, oxygen homeostasis and the regenerative potential of tissues and organs. His educational background includes a Bachelor of Science degree from Youngstown State University and a Ph.D. in Nutritional Sciences from the University of Maryland. He currently serves on the Board of Trustees of the University of Maryland Foundation and was appointed in 2016 to the Life Sciences Advisory Board by Governor Lawrence J. Hogan, Jr. Additionally, Dr. Chacon is the founding chair of The Board of Visitors of the University of Maryland Graduate School.
Listed skills include Technology Transfer, Drug Development, Gmp, Cell Biology, and 24 others.
Current workplace
Marco A. Chacón's current company
Company context helps verify the profile and gives searchers a useful next step.
6 roles · 37 years
Marco A. Chacón work experience
A career timeline built from the work history available for this profile.
Chairman Of The Board
CurrentPart of MLP Ventures, The Discovery Labs is a global provider of world-class cGMP manufacturing, turnkey laboratory solutions, critical materials and office space that support therapeutic products and services to the biotechnology and pharmaceutical industry so that groundbreaking medicines get to the patients that need them. The location in eastern King of Prussia is a prototype for a global rollout of The Discovery Labs, providing Big Pharma, emerging life sciences, consumer and technology companies flexible, end-to-end technical real estate and business infrastructure for the customer's entire lifecycle from discovery to delivery, including manufacturing capacity. It is the first fully integrated environment that merges technology and life sciences under one roof to drive innovation.
Jan 2020 - Present
Founder & President
Current
Irazú Bio
IRAZÚ Bio-holdings de-risks, translates and increases the value of intellectual property assets, while bridging the uncertainty divide between academic research and drug development. IRAZÚ incubates early stage ideas through preclinical, pivotal proof of concept studies and into Phase 1 clinical trials. Promising technologies will be spun off either as new companies or through licensing agreements with pharmaceutical and biotechnology companies. At the outset, IRAZÚ will leverage innovative biochemical mechanisms described in hypoxia tolerant and neuroprotected phenotypes, including caloric restriction models, newborn mammals and hibernators to promote survival, prevent disease and improve quality of life in old age. The company also holds partnerships in the fields of immuno-oncology and gene therapy. The IRAZÚ model will continue to add new projects emanating from university and federal agencies.
Sep 2019 - Present
Avp, Industry Alliances
Feb 2017 - Sep 2019
Founder & Chairman Of The Board Of Directors
Paragon Bioservices, Inc.
Jan 2016 - Feb 2017
President & Ceo
Paragon Bioservices, Inc.
Contract research and GMP manufacturing organization (CMO) with a focus on the development and manufacturing of biopharmaceuticals—either for research purposes or clinical trials
1990 - Jan 2016
1 education record
Marco A. Chacón education
-
University Of Maryland
FAQ
Frequently asked questions about Marco A. Chacón
Quick answers generated from the profile data available on this page.
What company does Marco A. Chacón work for?
Marco A. Chacón works for Irazu Oncology.
What is Marco A. Chacón's role at Irazu Oncology?
Marco A. Chacón is listed as Founder and President at Irazu Oncology.
What is Marco A. Chacón's email address?
AeroLeads has found 1 work email signal at @paragonbioservices.com for Marco A. Chacón at Irazu Oncology.
What is Marco A. Chacón's phone number?
AeroLeads has found 2 phone signal(s) with area code 410 for Marco A. Chacón at Irazu Oncology.
Where is Marco A. Chacón based?
Marco A. Chacón is based in Baltimore, Maryland, United States while working with Irazu Oncology.
What companies has Marco A. Chacón worked for?
Marco A. Chacón has worked for Irazu Oncology, Center For Breakthrough Medicines, Irazú Bio, University Of Maryland Baltimore, and Paragon Bioservices, Inc..
How can I contact Marco A. Chacón?
You can use AeroLeads to view verified contact signals for Marco A. Chacón at Irazu Oncology, including work email, phone, and LinkedIn data when available.
What schools did Marco A. Chacón attend?
Marco A. Chacón holds Phd, Nutritional Sciences from University Of Maryland.
What skills is Marco A. Chacón known for?
Marco A. Chacón is listed with skills including Technology Transfer, Drug Development, Gmp, Cell Biology, Cell Culture, Clinical Trials, Biochemistry, and Vaccines.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial